Novo Nordisk says EMA advisory panel recommends Tresiba
COPENHAGEN (Reuters) – Denmark's Novo Nordisk, the world's biggest insulin producer, said on Friday the advisory panel to the European … Continue reading →
View ArticleNovo Nordisk wins EU agency backing for new insulin
LONDON/COPENHAGEN (Reuters) – Novo Nordisk's ultra long-acting insulin Tresiba has been recommended for approval by the European Medicines Agency in … Continue reading →
View ArticleNovo Nordisk raises year view after Q3 beats fcasts
COPENHAGEN (Reuters) – Denmark's Novo Nordisk lifted third-quarter core profit by 40 percent and above expectations on the back of … Continue reading →
View ArticleNovo Nordisk insulin Ryzodeg passes Japan review
COPENHAGEN (Reuters) – Denmark's Novo Nordisk, the world's biggest insulin producer, said on Monday its Ryzodeg insulin had passed the … Continue reading →
View ArticleNovo Nordisk hit hard by U.S. blow to insulin drug
COPENHAGEN (Reuters) – U.S. regulators dealt a major blow to Novo Nordisk's hopes for its new long-acting insulin Tresiba by … Continue reading →
View ArticleNovo Nordisk "pleased" with obesity trial results
COPENHAGEN (Reuters) – Denmark's Novo Nordisk, the world's biggest insulin producer, said on Monday sufferers of Type 2 diabetes achieved … Continue reading →
View ArticleBatches of Novo Nordisk insulin face European recall
LONDON (Reuters) – The European Medicines Agency said on Friday that some batches of Novo Nordisk's insulin products NovoMix 30 … Continue reading →
View ArticlePolice probe Novo Nordisk for late disclosure of drug setback
By Shida Chayesteh COPENHAGEN (Reuters) – Novo Nordisk, the world's largest insulin maker, is facing a Danish police probe after … Continue reading →
View ArticleDenmark’s Novo Nordisk sued in U.S. over generic Prandin
Denmark's Novo Nordisk has been sued by a group of healthcare purchasing companies in the United States for allegedly wrongfully … Continue reading →
View ArticleNovo Nordisk diabetes drug appears effective for weight loss: study
Novo Nordisk's big-selling diabetes drug Victoza appears to be an effective weight loss therapy, data from a late-stage clinical trial … Continue reading →
View Article
